CNS Pharmaceuticals, Inc. short interest in 2023
In 2023, CNS Pharmaceuticals, Inc.'s disclosed short interest ran from 0.47% of shares outstanding on 31 Mar 2023 to 1.03% on 15 Dec 2023, a change of +0.56 percentage points. The year's high was 2.91% on 31 Aug 2023 and its low 0.45% on 15 Nov 2023, averaging 1.33% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 2.39 days on 13 Oct 2023. Full history: CNS Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 0.47% (31 Mar 2023)
- End of year
- 1.03% (15 Dec 2023)
- Change
- +0.56 pp
- High
- 2.91% (31 Aug 2023)
- Low
- 0.45% (15 Nov 2023)
- Average
- 1.33%
- Highest days to cover
- 2.39 (13 Oct 2023)
- SEC filings marked
- 7
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 31 Mar 2023 | 0.47% | 1.00 | 10-K filed |
| 15 Aug 2023 | 1.72% | 1.00 | 10-Q filed, results (8-K), 10-Q filed, results (8-K) |
| 31 Aug 2023 | 2.91% | 1.00 | |
| 15 Sep 2023 | 1.59% | 1.74 | |
| 29 Sep 2023 | 1.46% | 1.61 | |
| 13 Oct 2023 | 1.79% | 2.39 | |
| 31 Oct 2023 | 1.13% | 1.00 | |
| 15 Nov 2023 | 0.45% | 1.00 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 0.79% | 1.00 | |
| 15 Dec 2023 | 1.03% | 1.00 |
See also: CNS Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.